- AstraZeneca CFO Discusses AI Integration and Earnings Performance
AstraZeneca Chief Financial Officer Aradhana Sarin highlights the company's extensive use of AI across its operations. She also discusses the company's strong earnings performance and its drug pipeline during an interview on Bloomberg Surveillance.
Earnings·1 article / 1 outlet·19d ago
- FTSE 100 Set to Outperform Amid Tech Sell-Off
UK stocks are poised to outperform as the technology sector experiences a sell-off. The FTSE 100 index is showing resilience despite broader market fluctuations.
Macro·1 article / 1 outlet·20d ago
- China's Speed in Clinical Trials Draws Drugmakers Roche, AstraZeneca, Novartis
More pharmaceutical companies are taking early-stage research to the country, but questions remain over safety and transparency.
Macro·1 article / 1 outlet·20d ago
- AstraZeneca and Insitro Ink $1.86 Billion AI Drug Discovery Deal
AstraZeneca Plc is collaborating with machine learning biotech Insitro Inc. in a deal worth as much as $1.86 billion intended to help the British drugmaker find new medicines for the liver and heart.
Deals·1 article / 1 outlet·35d ago
- AstraZeneca Opens New R&D Center in Kendall Square with $1 Billion Investment
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Macro·2 articles / 2 outlets·43d ago·◆ Primary source
- AstraZeneca Opens New R&D Center in Kendall Square with $1 Billion Investment
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Macro·2 articles / 2 outlets·43d ago·◆ Primary source
- AstraZeneca Opens New R&D Center in Kendall Square with $1 Billion Investment
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Macro·2 articles / 2 outlets·43d ago·◆ Primary source
- AstraZeneca Opens New R&D Center in Kendall Square with $1 Billion Investment
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Macro·2 articles / 2 outlets·43d ago·◆ Primary source
- AstraZeneca Opens New R&D Center in Kendall Square with $1 Billion Investment
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Macro·2 articles / 2 outlets·43d ago·◆ Primary source
- AstraZeneca Opens New R&D Center in Kendall Square with $1 Billion Investment
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Macro·2 articles / 2 outlets·43d ago·◆ Primary source
- AstraZeneca Opens New R&D Center in Kendall Square with $1 Billion Investment
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Macro·2 articles / 2 outlets·43d ago·◆ Primary source
- AstraZeneca Opens New R&D Center in Kendall Square with $1 Billion Investment
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Macro·2 articles / 2 outlets·43d ago·◆ Primary source